Analysts forecast that Viveve Medical Inc (NASDAQ:VIVE) will post sales of $3.37 million for the current quarter, according to Zacks. Three analysts have made estimates for Viveve Medical’s earnings, with the highest sales estimate coming in at $4.15 million and the lowest estimate coming in at $2.90 million. Viveve Medical reported sales of $3.70 million in the same quarter last year, which would suggest a negative year over year growth rate of 8.9%. The business is expected to announce its next quarterly earnings report on Thursday, May 9th.
On average, analysts expect that Viveve Medical will report full-year sales of $19.48 million for the current financial year, with estimates ranging from $19.00 million to $20.05 million. For the next financial year, analysts expect that the business will report sales of $28.60 million, with estimates ranging from $24.65 million to $34.07 million. Zacks Investment Research’s sales calculations are an average based on a survey of research analysts that follow Viveve Medical.
VIVE has been the subject of several analyst reports. Maxim Group restated a “buy” rating and issued a $6.00 target price on shares of Viveve Medical in a research report on Monday, February 11th. Mizuho restated a “buy” rating and issued a $4.00 target price on shares of Viveve Medical in a research report on Friday, March 15th. Finally, Craig Hallum set a $1.00 target price on shares of Viveve Medical and gave the company a “hold” rating in a research report on Friday, January 18th. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $3.50.
Viveve Medical stock traded down $0.02 during midday trading on Friday, hitting $0.48. The company’s stock had a trading volume of 328,421 shares, compared to its average volume of 316,008. The stock has a market capitalization of $23.02 million, a price-to-earnings ratio of -0.30 and a beta of 0.70. The company has a quick ratio of 3.51, a current ratio of 3.89 and a debt-to-equity ratio of 6.21. Viveve Medical has a 1-year low of $0.47 and a 1-year high of $4.34.
About Viveve Medical
Viveve Medical, Inc designs, develops, manufactures, and markets medical devices for the non-invasive treatment of various post-partum conditions. The company offers Viveve System, a radio frequency generator, a reusable hand piece, and single-use treatment tip, as well as other consumable components.
Further Reading: How to Invest in an Index Fund
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Viveve Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viveve Medical and related companies with MarketBeat.com's FREE daily email newsletter.